SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Eloise Larson, Ian Fyfe, A. Jennifer Morton, Darren G. Monckton, Age-, tissue- and length-dependent bidirectional somatic CAG•CTG repeat instability in an allelic series of R6/2 Huntington disease mice, Neurobiology of Disease, 2015, 76, 98

    CrossRef

  2. 2
    Niko Hensel, Sebastian Rademacher, Peter Claus, Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders, Frontiers in Neuroscience, 2015, 9,

    CrossRef

  3. 3
    Ilyas Yildirim, Debayan Chakraborty, Matthew D. Disney, David J. Wales, George C. Schatz, Computational Investigation of RNA CUG repeats responsible for Myotonic Dystrophy 1, Journal of Chemical Theory and Computation, 2015, 150828152458006

    CrossRef

  4. 4
    Kyle D Fink, Peter Deng, Audrey Torrest, Heather Stewart, Kari Pollock, William Gruenloh, Geralyn Annett, Teresa Tempkin, Vicki Wheelock, Jan A Nolta, Developing stem cell therapies for juvenile and adult-onset Huntington's disease, Regenerative Medicine, 2015, 10, 5, 623

    CrossRef

  5. 5
    Praveen Dayalu, Roger L. Albin, Huntington Disease, Neurologic Clinics, 2015, 33, 1, 101

    CrossRef

  6. 6
    Udo Rüb, Kay Seidel, Jean Paul Vonsattel, Herwig W. Lange, Wolfgang Eisenmenger, Monika Götz, Domenico Del Turco, Mohamed Bouzrou, Horst-Werner Korf, Helmut Heinsen, Huntington's Disease (HD): Neurodegeneration of Brodmann's Primary Visual Area 17 (BA17), Brain Pathology, 2015, 25, 5
  7. 7
    Ori Staszewski, Marco Prinz, Glial epigenetics in neuroinflammation and neurodegeneration, Cell and Tissue Research, 2014, 356, 3, 609

    CrossRef

  8. 8
    Hollis McClory, Dana Williams, Ellen Sapp, Leah W Gatune, Ping Wang, Marian DiFiglia, Xueyi Li, Glucose transporter 3 is a rab11-dependent trafficking cargo and its transport to the cell surface is reduced in neurons of CAG140 Huntington’s disease mice, Acta Neuropathologica Communications, 2014, 2, 1, 179

    CrossRef

  9. 9
    Udo Rüb, Matthias Hentschel, Katharina Stratmann, Ewout Brunt, Helmut Heinsen, Kay Seidel, Mohamed Bouzrou, Georg Auburger, Henry Paulson, Jean-Paul Vonsattel, Herwig Lange, Horst-Werner Korf, Wilfred Dunnen, Huntington's Disease (HD): Degeneration of Select Nuclei, Widespread Occurrence of Neuronal Nuclear and Axonal Inclusions in the Brainstem, Brain Pathology, 2014, 24, 3
  10. 10
    Michal Mizrahi, Yael Friedman-Levi, Liraz Larush, Kati Frid, Orli Binyamin, Dvir Dori, Nina Fainstein, Haim Ovadia, Tamir Ben-Hur, Shlomo Magdassi, Ruth Gabizon, Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD, Nanomedicine: Nanotechnology, Biology and Medicine, 2014, 10, 6, 1353

    CrossRef

  11. 11
    Anna Bassols, Cristina Costa, P. David Eckersall, Jesús Osada, Josefa Sabrià, Joan Tibau, The pig as an animal model for human pathologies: A proteomics perspective, PROTEOMICS - Clinical Applications, 2014, 8, 9-10
  12. 12
    Andrew Crane, Julien Rossignol, Gary Dunbar, Use of Genetically Altered Stem Cells for the Treatment of Huntington’s Disease, Brain Sciences, 2014, 4, 1, 202

    CrossRef

  13. 13
    K Fink, A Crane, J Rossignol, L Lescaudron, G Dunbar, Stem Cells and Neurodegenerative Diseases, 2014,

    CrossRef

  14. 14
    Ilyas Yildirim, HaJeung Park, Matthew D. Disney, George C. Schatz, A Dynamic Structural Model of Expanded RNA CAG Repeats: A Refined X-ray Structure and Computational Investigations Using Molecular Dynamics and Umbrella Sampling Simulations, Journal of the American Chemical Society, 2013, 135, 9, 3528

    CrossRef

  15. 15
    Udo Rüb, Ludger Schöls, Henry Paulson, Georg Auburger, Pawel Kermer, Joanna C. Jen, Kay Seidel, Horst-Werner Korf, Thomas Deller, Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7, Progress in Neurobiology, 2013, 104, 38

    CrossRef

  16. 16
    Marguerite V. Evans-Galea, Anthony J. Hannan, Nissa Carrodus, Martin B. Delatycki, Richard Saffery, Epigenetic modifications in trinucleotide repeat diseases, Trends in Molecular Medicine, 2013, 19, 11, 655

    CrossRef

  17. 17
    Emily Oster, Ira Shoulson, E. Ray Dorsey, Limited Life Expectancy, Human Capital and Health Investments, American Economic Review, 2013, 103, 5, 1977

    CrossRef

  18. 18
    Emily Oster, Ira Shoulson, E. Ray Dorsey, Optimal Expectations and Limited Medical Testing: Evidence from Huntington Disease, American Economic Review, 2013, 103, 2, 804

    CrossRef

  19. 19
    Joohi Jimenez-Shahed, Joseph Jankovic, Tetrabenazine for treatment of chorea associated with Huntington's disease and other potential indications, Expert Opinion on Orphan Drugs, 2013, 1, 5, 423

    CrossRef

  20. 20
    F. Yokoi, M. T. Dang, T. Zhou, Y. Li, Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models, Human Molecular Genetics, 2012, 21, 4, 916

    CrossRef

  21. 21
    Xueyi Li, Antonio Valencia, Hollis McClory, Ellen Sapp, Kimberly B. Kegel, Marian DiFiglia, Deficient Rab11 activity underlies glucose hypometabolism in primary neurons of Huntington’s disease mice, Biochemical and Biophysical Research Communications, 2012, 421, 4, 727

    CrossRef

  22. 22
    Federico Benetti, Stefano Gustincich, Giuseppe Legname, Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits, Expert Opinion on Drug Discovery, 2012, 7, 3, 245

    CrossRef

  23. 23
    Ralf Reilmann, Huntington’s disease: Towards disease modification – Gaps and bridges, facts and opinions, Basal Ganglia, 2012, 2, 4, 241

    CrossRef

  24. 24
    Arulmani Manavalan, Lin Feng, Siu Kwan Sze, Jiang-Miao Hu, Klaus Heese, New insights into the brain protein metabolism of Gastrodia elata-treated rats by quantitative proteomics, Journal of Proteomics, 2012, 75, 8, 2468

    CrossRef

  25. 25
    Beverly L Davidson, Taking a Break From Huntingtin, Molecular Therapy, 2012, 20, 10, 1838

    CrossRef

  26. 26
    Beverly L Davidson, Taking a Break From Huntingtin, Molecular Therapy — Nucleic Acids, 2012, 1, 8

    CrossRef

  27. 27
    Tamara Pringsheim, Katie Wiltshire, Lundy Day, Jonathan Dykeman, Thomas Steeves, Nathalie Jette, The incidence and prevalence of Huntington's disease: A systematic review and meta-analysis, Movement Disorders, 2012, 27, 9